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previous WHO editions. This reduction in the “normal” range may be 
a retrograde step with 15% of men previously classified as sub‑fertile 
and treated accordingly, now being classified in the normal or fertile 
range and investigated no further.4 The usefulness of a semen analysis 
to predict ART outcomes is also limited in in vitro fertilization (IVF)5 
and of no consequence in intracytoplasmic sperm injection (ICSI). 
In an attempt to find a better test, studies have been performed at the 
molecular level to assess sperm health over the past 20 years. From this 
research, two important issues have emerged. First, there is consensus 
that men in infertile couples have more sperm DNA damage than those 
in the general population or men who have recently fathered a child. 
Second, this damage points to a newly recognized, and potentially 
dangerous, although possibly preventable, cause of male infertility.
A plethora of studies has also concluded that DNA damage could 
be a more accurate diagnostic tool for male infertility. This criterion 
of sperm quality is also useful as a predictor of ART success at each 
checkpoint in the reproductive process including impaired fertilization, 
erratic preimplantation embryo development, miscarriage, and birth 
defects in the offspring.6
DNA damage in sperm is primarily from oxidative stress (OS).6 
In a semen sample from any man, most of the sperm look abnormal 
even under light microscopy.3 The sperm that exhibits such OS are 
those morphologically abnormal cells that were should have been 
removed by apoptosis, but the process was only half finished. Other 
sperm experiencing OS are those with defective protamine packaging 
from abnormal spermiogenesis. Current WHO guidelines suggest that 
even in fertile men, 96% of their sperm are morphologically abnormal, 
many with excess residual cytoplasm, allowing them to generate 
excessive reactive oxygen species (ROS), which given their incomplete 
chromatin packaging, allows greater access to DNA and induction 
of damage.6 Unfortunately, as sperm have few repair mechanisms, 
INTRODUCTION
Given that up to 5% of the children born in the Western world are 
currently conceived by assisted reproductive technology (ART) and 
the number of couples presenting with infertility is increasing 8%–9% 
year on year, the health of male and female gametes and the offspring 
born from them is paramount.1 Although over 5 million babies have 
been born worldwide, success has always been measured in terms of 
early embryo quality and implantation; seldom are live birth rates cited 
and even less often is consideration given to the short or long‑term 
health of the child. While these checkpoints are vital to fertility clinic 
survival and to individual couple satisfaction, they are inadequate for 
society at large. We need information on the birth‑to‑death health 
and wellbeing of children conceived by ART. In economic terms, 
we need to determine if the benefits outweigh the costs of creating 
and providing for this ART conceived subpopulation. The evidence 
begins, although it does not end with, the impact of measurable semen 
properties on ART outcomes. The impact of the paternal genome on 
the life of the offspring from cradle to grave is rather more important 
to both parents and Society.
THE EFFECTS OF SEMEN ANALYSIS PROPERTIES ON 
DIAGNOSIS OF MALE INFERTILITY AND PREDICTION OF 
ASSISTED REPRODUCTIVE TECHNOLOGY OUTCOMES
Fertility problems are almost equally divided between male and 
female partners with male infertility being indicated in more than 
40% of couples presenting for treatment with ART. Traditional semen 
analysis is still used as a standard routine test to diagnose this condition 
although as a purely descriptive evaluation, it cannot discriminate 
between the sperm of fertile and infertile men.2 This understanding is 
mirrored in the variable thresholds for normality (all “normal” values 
now lower) in the 5th edition of the WHO manual,3 compared to the 
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DNA damage is commonly encountered in these cells even within 
fertile donor population.6 However, it is the amount of damage that 
is most closely associated with poorer ART outcomes. For any test 
to be clinically useful, it must have a threshold value which provides 
adequate discriminatory power. Routine semen analysis falls short of 
these standards,5,7,8 so improved assays are needed.
DNA damage has long been the recognized universal indicator 
of cell lethality in toxicology laboratories in the pharmaceutical 
industry. The same is true of sperm. Sperm DNA damage is a robust 
gauge of cellular poor health. With advances in ART, we can now 
achieve fertilization in vitro with sperm that would have been rejected 
in vivo. However, by using sperm with compromised DNA for assisted 
conception, we are risking the long‑term health and wellbeing of 
children conceived by ART. As a matter of “best practice,” we should be 
testing the DNA quality of male gametes before using them clinically.
THE STRENGTH OF SPERM DNA TESTING
DNA fragmentation testing has a high level of repeatability in 
comparison9 to the high intra‑individual variations of concentration, 
motility, and morphology as measured in a conventional semen analysis.5 
Previous studies have reported high levels of repeatability (CV ~ 10%) 
in men with low levels of DNA damage.10,11 In a recent large study, the 
intra‑individual CV for DNA damage  (using the sperm chromatin 
structure assay) was higher (30%) but 85% of the men from infertile 
couples did not change subgroup from one test to the next, with 
respect to the clinical cut‑off level of 30%, still supporting the concept 
that a single sperm DNA damage test has a high predictive value for 
assessing male infertility. Other studies comparing semen from fertile 
donors with men presenting for infertility investigations (using the 
Comet assay) report sensitivity of 63% and specificity of 98% for 
the diagnosis of male infertility. This resulted in a receiver operating 
characteristic (ROC) of 0.970. Similarly, in testing DNA damage in 
native semen to predict clinical pregnancy, the sensitivity was 95%, and 
specificity was 80% with a ROC of 0.905, again indicating a robust test. 
In the context of DNA damage testing, both sensitivity and specificity of 
the test are important as they correctly identify those without damage 
who would benefit from IVF and those with damage who can then be 
guided toward ICSI rather than IVF.
THE ORIGINS AND CHARACTER OF DNA DAMAGE
Sperm chromatin differs from somatic cells in both components and 
structure. During spermiogenesis, protamines12 that are half the size 
of histones,13 replace the majority of histones, and the chromatin 
is rearranged into unique supercoiled doughnut structures named 
toroids.13 As the sperm transit through the epididymal tract, the 
protamines are cross‑linked by disulfide bonds. This shrinks the 
chromatin volume to one‑sixth of that in somatic cell nuclei. This added 
compaction gives protection to the sperm DNA against exogenous assault. 
This is seen in the high levels of irradiation needed to destroy sperm DNA, 
in comparison with somatic cells14 and also by the high concentrations 
of hydrogen peroxide required to damage either sperm nuclear or 
mitochondrial genomes.15 However, if this protamination is incomplete, 
as in some infertile men, the DNA strands that are scantily compacted 
are vulnerable to damage, observed as double and single strand breaks, 
abasic sites, inter‑strand cross‑links, and DNA‑protein cross‑links.15
Damaged DNA has been reported in sperm at all stages: from 
the testis, epididymis, and ejaculate. Sperm DNA first becomes 
susceptible to damage if chromatin packing is not completed during 
spermatogenesis.16,17 Some strand breaks may be required to decrease 
the torsional stress that occurs for the tertiary structural reorganization 
during the elongation of spermatids. Normally, these nicks are 
transitory. If they are not corrected,18,19 increased DNA damage will 
be present in ejaculated sperm. Epididymal transit is another hazard 
for sperm when they are vulnerable to damage if incomplete disulfide 
cross‑linking has not been completed adequately.20
DNA repair occurs as sperm mature,18 but it is terminated as 
transcription and translation cease following spermiogenesis.21 This 
means that the damage that happens to DNA following germ cell 
differentiation into spermatocytes, spermatids, and spermatozoa 
cannot be corrected, although they may be undergoing apoptosis as 
reported by Fas expression or endonuclease activation.21,22 This may 
explain the residual level of DNA damage observed even in semen from 
fertile donors.23 Further genomic damage to healthy sperm can occur 
in the epididymis from adjacent ROS‑producing sperm, epithelial 
epididymal cells or through commonly present toxic or inflammatory 
factors. This is seen in the lower levels of DNA damage reported 
in testicular sperm increasing in caudal epididymal and further in 
ejaculated sperm.23–27 Suganuma’s group27 is also in agreement showing 
that a defective sperm experienced an increase in DNA damage during 
the passage through the epididymis. It is acknowledged that even the 
proximal epididymis has substantial proportions of senescent sperm26 
releasing ROS as they age and die28 and damaging those adjacent to 
them. This may, at least in part, explain the higher levels of sperm 
DNA damage in the epididymis. As with other indications of sperm 
dysfunction, the importance of ROS, produced by either increased ROS 
generation or impaired antioxidant defense, as a primary instigator 
of sperm DNA damage is well established.7 Sperm are particularly 
vulnerable to damage from ROS because of their high polyunsaturated 
fatty acid content and limited ability to repair damage. Sperm from 
infertile men are often associated with high levels of ROS caused by 
either increased production and/or impaired antioxidant defense.29,30 
Associations between OS and sperm DNA damage have been reported 
in numerous studies.31
Spontaneous germ‑line mutations are not always deleterious. 
Their presence in animals has the benefit of creating genetic diversity 
and thus progressing evolution. However, in the process of creating 
mutations, molecules such as 8‑oxoguanine (8‑oxoG) are associated 
with ROS in  vivo with very negative and immediate effects on the 
organism. In 2014, Ohno et al.32 have designed an elegant study using a 
triple knockout mouse; TOY‑KO in which three of the most important 
enzymes  (Mth1/Ogg1/Mutyh) that mammals possess to prevent 
8‑oxoG induced mutations were knocked out. This caused spontaneous 
and inheritable G to T mutations at different stages in the germ cell 
lineage with the mutations distributed throughout the chromosomes. 
The TOY‑KO mice were viable and fertile, but they had reduced 
survival, reduced fecundity, and a variety of life‑shortening cancers.
We have known for some time, again from animal models that 
the oocyte can provide limited repair to damaged sperm DNA 
postfertilization.33,34 It has also been observed in a small study35 where 
the pregnancy rate of a mixture of IVF and ISCI cycles was not reduced 
by poor quality sperm DNA with donor oocytes suggesting that young 
fertile oocytes can repair some DNA damage in sperm from older 
men. However, it has often been reported that damaged DNA does 
not impact on early ART outcomes with ICSI, in contrast to poorer 
results using IVF. In this context, Meseguer et al.36 investigated the 
effect of oxidative sperm DNA damage on ICSI outcomes using donor 
oocytes. Here, they reported that such damage led to an impairment 
of blastocyst formation. Clearly, these studies need to be extended in 
order to more fully resolve the oocyte’s ability to repair different kinds 
of DNA damage in sperm.
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What is not yet clear is whether the oocyte can repair 
double‑stranded or just single stranded DNA breaks. Furthermore, the 
threshold beyond which repair is impossible has not been investigated 
in humans, although a figure of 8% has been postulated in mice.37 If 
inadequately repaired by the oocyte, such sperm DNA damage can 
predispose to mutations in the developing offspring.31
THE BIOLOGICAL IMPORTANCE OF DNA DAMAGE FOR 
OFFSPRING
To assess the biological importance of good quality sperm DNA on 
offspring health, we need to focus on animal models as such studies 
would be unethical in humans.
In reproductive technology, the literature is irrefutable in 
recognizing DNA damage in the male germ line, as a negative factor 
in relation to embryo quality and on‑going pregnancy. In the dominant 
lethal assay, the male is given a toxicant, and the females, which have not 
been exposed, are examined over time to assess embryo number and 
quality and progression and miscarriage.38 Yet, of even more concern, 
if the conception results in a live birth, there may be an increased 
incidence of cancers and morbidity in the offspring.
A large range of toxicants, and, in particular, compounds that 
induce OS, cause DNA damage in sperm, and this is strongly 
associated with embryo loss and growth impairment. This literature 
has been carefully reviewed by Aitken et al.15 A milestone study, with 
particular relevance to ART is that of Fernández‑Gonzalez et  al.39 
This group performed ICSI with mouse spermatozoa in which DNA 
damage had been induced by cryo‑injury. The aim of their study was 
to investigate the long‑term consequences on offspring of using a 
damaged paternal genome. Cryo‑injury led to DNA strand breaks 
and loss of telomeres. Fertilization by ICSI with these DNA‑damaged 
sperm led to preimplantation embryo development, albeit at a slower 
rate than control animals. The number of offspring per litter was also 
reduced. Methylation of some epigenetically regulated genes was 
altered. Animals exhibited increased anxiety, lack of a habituation 
pattern and a defective spatial memory (P < 0.05). At 16 months, 33% of 
females produced with DNA‑fragmented sperm presented some solid 
tumors in lungs and dermis. Moreover, 20% of the mice died during 
the first 5 months of life, with 25% of the surviving animals showing 
premature aging symptoms. The authors suggested that the oocytes had 
been able to partially repair fragmented DNA, producing blastocysts 
able to implant and produce live offspring. However, the repair was 
incomplete, thus leading to long‑term pathologies. The fact that these 
anomalies were only observed in later life is of concern, given that the 
oldest ICSI children are only in their 20’s.
Many compounds capable of inducing such damage are widely 
present in our everyday lives. These include spray adhesives and glues 
containing 1‑bromopropane, fried food with acrylamide, radiation, 
chemotherapeutic agents, and metals such as nickel and iron that can 
lead to OS.38,40
Other potential toxicants occur in unexpected situations. Two 
examples of this are the widely used drugs; Sildenafil citrate for 
erectile dysfunction and streptozotocin that is used in treating certain 
diabetic cancers. Further, work from our laboratory has shown that 
men with type 1 and type 2 diabetes have already had high levels of 
oxidative damage in their sperm although their semen analyses may 
appear normal.41,42 As Sildenafil citrate is often used in fertility clinics 
for male patients having difficulties in producing a semen sample and 
also in the treatment of young diabetic men to restore potency, we 
used an animal model to assess the effects of sildenafil‑treated males 
on fertilization and embryo development in unexposed females. Pups 
were born following treatment although both fertilization and embryo 
development were impaired.43
The toxic effects on embryo development may be due to 
phosphodiesterase  (PDE) inhibitor effects on the embryo’s DNA 
synthesis and repair. Pentoxifylline  (a PDE type  4 inhibitor), also 
used in fertility clinics to improve poor sperm motility has also been 
shown to inhibit DNA repair in  vitro during the S and G2 phases 
in a human ovarian cell line.44,45 Furthermore, DNA mutations can 
be increased with milrinone; a PDE type  3 inhibitor,46 suggesting 
more than one pathway by which PDE inhibitors act on DNA. In 
support of these animal studies, a recent human study has reported 
a negative correlation between sperm DNA oxidative damage after 
fertilization and blastocyst formation.36 Again, such impairments in 
the development do not preclude the birth of offspring that may have 
on‑going health issues.
In order to elucidate the mechanisms by which human offspring 
health is affected by paternal genomic damage, we can use indirect, 
but powerful paradigms: paternal ageing and smoking.
AGEING AND PATERNAL GENOME
It has always been clear to women that there is a natural endpoint, albeit 
over a period of years, to their childbearing years. In contrast, men have 
been viewed traditionally as retaining their ability to father a child until 
their old age. However, insufficient studies have explored the impact of 
the advanced paternal age on the health and wellbeing of such offspring. 
Far from viewing advanced paternal age as a possible disadvantage, 
media coverage of older male celebrities with their latest children has 
been met with approval and acceptance. Second, in today’s changing 
society, many men begin new partnerships with younger women who 
wish to have a family for the first time. Reproductive technologies 
have made this possible even for vasectomized men as ART with 
testicular sperm is a successful option. Furthermore, there appears to 
be a worldwide trend for leaving the initiation of a family until later 
in life.47,48 It is difficult to perform studies on paternal age and child 
health. Paternal information is often missing from birth certificates; in 
the USA, for example, father’s age is missing from ~ 15% of all births.47
Over the past decade, an interest in aged fathers has been 
developed, concomitant with the increased interest in andrology, in 
general. As men age, they do not stop producing sperm, however, 
the gametes they do produce exhibit a progressive loss of quality, 
particularly in terms of DNA integrity.49,50 Spermatogenesis consists 
of replication of spermatogonial stem cells throughout a man’s life. 
This involves countless cell divisions, and more mitotic cell divisions 
occur, the more chance of chromosomal errors occurring too. This has 
been reported in numerous recent reviews indicating a link between 
reduced genomic quality and mutational load in the male germ line 
and developmental abnormalities in the embryo; exemplified by age.49,51 
Although the types of DNA damage observed in the sperm of ageing 
males have not yet been fully characterized, it is clear that as men age, 
the risk of morbidity in their offspring increases.
For many years, paternal age has been recognized as the major 
contributor to poor offspring health, as reflected by spontaneous 
dominant genetic diseases such as achondroplasia or Apert syndrome 
and in a variety of complex polygenic neurological disorders such as 
epilepsy, spontaneous schizophrenia, autism, and bipolar disease.52–54 
Further, advanced paternal age is associated with a trinucleotide 
repeat associated diseases such as Huntington’s disease and myotonic 
dystrophy.54–57 Paternal age has also been linked with birth defects (neural 
tube defects, congenital cataracts, reduction defects of the upper limb 
and Down syndrome); however, these effects are not particularly 
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strong and tend to be inconsistent.58,59 DNA lesions in the sperm of 
ageing fathers are also associated with an increased risk of cancer in 
the offspring.60 In the cohort of all children (1.8 million) born alive in 
Denmark from January 1, 1978 to December 31, 200461 there was also a 
statistically significant increased risk of mortality (1.65, 95% confidence 
interval [CI]:1.2–2.18) in offspring under 5 years of age if fathers were 
45+ years compared to 30–34 years. The risk was attributed to congenital 
malformations and malignancies. As older fathers are increasing in the 
first world, this association will become of even greater importance.
In a large population‑based study62 of 2.6 million Swedish 
children born between 1973 to 2001, the risk of psychiatric and 
academic morbidity as a result of advancing paternal age was explored. 
Quasi‑experimental designs were used to compare differentially 
exposed siblings and cousins. Childhood and adolescent morbidity 
were also investigated. Comparing paternal ages of 20–24 years with 
45 years and older, the authors reported an association between an 
increased risk of the following psychiatric syndromes with advancing 
age: autism, psychosis and bipolar disorders. When the offspring of 
fathers (20–24 years) were compared with those of fathers of > 45 years, 
this was also true but also included additional associations with 
psychiatric and academic morbidity in the form of suicide attempts, 
substance abuse problems and low educational attainment. The 
magnitude of risk was larger than in previous estimates. In support 
of these findings are those of another large population‑based 
Scandinavian study63 of 2.8 million children born in Denmark between 
1955 and 2011. Again, offspring of older fathers were at an increased 
risk of mental retardation and autism spectrum disorders.
Although there is strong epidemiological evidence that the diseases 
listed above are more common in offspring from older fathers, the 
mechanisms by which they occur are still unclear. De novo genetic 
mutations that can occur during spermatogenesis and/or epigenetics, 
and specifically DNA methylation alterations are the most likely 
candidates. In a unique study in 2012 by Kong’s group and published 
in Nature the effects of paternal age on fertility de novo mutations 
and disease risk were examined.64 The group conducted a study 
of genome‑wide mutation rate by sequencing the genomes of 219 
individuals consisting of 78 trios  (father, mother, and child). They 
reported that the diversity in mutation rates of single‑nucleotide 
polymorphisms is dominated by the age of the father, not the mother, at 
conception of the child. The effect is an increase of about two mutations 
per year. This extrapolates to a 20‑year‑old father transferring about 
25 de novo mutations to his offspring compared to a 40‑year‑old man 
who could pass on 65 de novo mutations. The implications of this study 
are controversial. While there may be a connection between advanced 
paternal age and polygenic psychiatric disorders, mutations are an 
important part of evolutionary diversity and the number of mutations 
is very small compared to the total numbers of genes in the overall 
DNA code. In addition, the group reported that the rate of human 
mutations was lower than previously estimated.
In a study by Carrell’s group,65 the influence of paternal aging on 
DNA methylation in human sperm was investigated using a methylation 
array approach in 17 fertile donors by comparing the sperm methylome 
of two samples collected 9–19 years apart from each individual. The 
group found numerous regions of methylation alterations (promotor 
or gene body) that were hypomethylated with age. Further, some of the 
age‑related changes in sperm DNA methylation are located at genes 
previously associated with schizophrenia and bipolar disorder. Overall, 
it would appear that multifactorial genetic and epigenetic disorders that 
cause impaired brain function and lead to autism, schizophrenia, and 
academic morbidity are associated with a paternal age effect.
SMOKING
Cigarette smoking has been shown to increase oxidative DNA damage 
in sperm66 male offspring fertility67 and also cancer in offspring.68,69 
However, it has been difficult to separate effects of paternal and 
maternal smoking on offspring health. To address this limitation of 
earlier studies, Ji et al.45 conducted a population‑based, case‑control 
study of childhood cancer in Shanghai, People’s Republic of China, 
where the prevalence of cigarette smoking is high among men but 
very low among women with only 1% of young adult females being 
smokers.70,71 This study provided a one‑off chance to evaluate the role 
of paternal smoking, in the preconceptual period and the absence 
of maternal smoking on the cause of childhood cancer. The study 
included 642 childhood cancer case patients (<15 years of age) and 
their individually matched control subjects. Information about the 
exposure of the child to parental smoking was obtained by interviewing 
both parents.
The effect of paternal cigarette smoking on childhood cancer 
was shown to begin in the preconception period with elevated risks 
of childhood acute leukemia, lymphoma, brain tumors, and total 
cancers. The significantly increased relative risks to cancers were 
mostly observed in young children diagnosed before 5 years old. They 
speculated that paternal smoking induces prezygotic genetic damage 
that, in turn, acts as a predisposing factor for cancers. More recently, a 
meta‑analysis of 12 studies was undertaken to search for associations 
between paternal smoking and childhood leukemia risk.72 Paternal 
smoking at home was significantly (1.8, 95% CI: 1.1–2.8) associated 
with all leukemias. Following on, the effects of paternal smoking on 
general female childhood health through to adulthood was investigated 
using data from 35 370 participants in the Nurses’ Health Study II.73 
Women whose fathers smoked during their mother’s pregnancy 
were also at an increased risk of being overweight or obese during in 
adulthood with the risk increasing as with the number of cigarettes 
smoked compared with nonsmoking fathers. Paternal smoking 
during pregnancy was not associated with childhood body size. This 
association persisted after adjustment for maternal smoking.
Adding these two paradigms of ageing and smoking from 
epidemiological studies to the direct evidence showing cause and effect 
in animal models, generates a compelling package of data implicating 
the paternal genome in the health of progeny from fertilization, 
pregnancy, and its maintenance through to the short‑ and long‑term 
fitness of children’s lives.
THE HEALTH OF CHILDREN BORN BY IN VITRO FERTILIZATION 
AND INTRACYTOPLASMIC SPERM INJECTION
The number of children born as a result of ART has now risen to 
7 million worldwide. In the first world countries, they account for up 
to 5% of all babies born, and the number of couples presenting with 
infertility is increasing 8%–9% each year across Europe.1
Until recently, the most important endpoint to most clinics and 
couples was a pregnancy but with time, we are realizing that there 
may be more health problems with ART conceived children and so 
studies on their on‑going mental and physical wellbeing is imperative. 
From 1978 to 2003, a few sparse publications had indicated that there 
were no increased risks. However, by 2005, the first systematic review 
was carried out by Hansen et al.74 of the 25 major studies about the 
prevalence of birth defects in infants conceived following IVF and/or 
ICSI compared with spontaneously conceived infants. All 25 studies 
indicated an increased risk of 30%–40% of birth defects related to ART.
Since then, the most detailed studies and reviews have been 
published by Bonduelle’s group in Belgium.75–78 There are many reports 
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of normal physical development up to 18 years in comparison with 
spontaneously conceived controls.79–83 The studies of children born 
following ICSI are mostly cross‑sectional evaluations at different 
ages from 5 to 12 years.84–90 Menarche and pubertal development of 
IVF and ISCI children are comparable to spontaneously conceived 
children91 although breast development in ICSI girls is delayed. All of 
these data came from children in Northern Europe. A comprehensive 
study from South Australia92 compared birth defects of 6163 children 
born from ART with 302 811 children born to couples with no record 
of infertility. They found that the overall risk of any birth defect 
following ART was 8.3%, compared to the significantly lower, 5.8%, 
in spontaneously conceived children. The most common birth defects 
connected to ART included spina bifida, cerebral palsy, cleft palate 
and musculoskeletal, cardiovascular and gastrointestinal conditions. 
The group then divided the risks for IVF and ICSI and found that 
ICSI resulted in the highest rate at 9.9% compared IVF at 7.2%. They 
also reported that this additional risk with IVF could be explained 
by patient characteristics, such as age or weight unlike the risk for 
ICSI that could not be thus explained. Interestingly, this difference 
was not observed with frozen‑thawed embryos, suggesting that the 
cryopreservation may act as a physiological filter whereby only the 
best embryos survive the assault.
Any concerns we have had about ICSI children have largely focused 
on boys and their potentially impaired fertility. To some surprise, in 
a large study in 2012, Belva et al.77 reported that ICSI girls were at 
risk of increased central, peripheral and total adiposity although boys 
appeared to be less affected with only an increase in peripheral skinfold 
being observed. The authors recommended that monitoring of body 
fat patterns in adolescents born after ART should be compulsory in 
order to assess their risk for developing obesity and taking avoidance 
measures to prevent adverse health effects in adulthood. In childhood 
and at puberty, however, elevated blood pressure, higher fasting 
glucose levels, generalized vascular dysfunction, and altered body 
fat distribution have been described in offspring from both IVF and 
ICSI.77–79 In a review of all the literature pertaining to health outcomes 
of IVF and ICSI children by the Evian Annual Reproduction workshop 
group (2014), the report concluded that IVF children have lower birth 
rates and higher peripheral fat, blood pressure, and fasting glucose 
levels than controls. However, the group was unable to ascertain if the 
differences were due to ART procedures per se or also to the duration 
of infertility and the age of the mother as well.93
In 2011, Belva et  al.76 examined the neonatal outcomes of 724 
children born after ICSI using nonejaculated sperm. They reported 
that stillborn rates, prematurity rates and low birth weight rates were 
comparable in surgically retrieved and ejaculated sperm groups. 
A nonsignificant increase in major anomalies was reported in offspring 
born from surgically retrieved sperm compared to ejaculated sperm, 
but the risk was higher than in the general population.
Further health and safety reassurance was recently reported in 
another large prospective register‑based cohort study, undertaken in 
Denmark between 1995 to 2003 of 33 139 children born after ART 
compared to 555 828 children who were spontaneous conceived. No 
increase in the incidence of mental health disorders was observed.94
In our haste to provide an infertility treatment for men with 
azoospermia, we neglected to perform the basic research to investigate 
the functions of seminal plasma on sperm health. We have assumed 
that seminal plasma’s only function was as a vehicle to transport 
sperm from male to female reproductive tract. Some exciting research 
has recently come from Robertson’s group in Adelaide showing that 
seminal plasma has many more functions and the absence of sperm/
seminal plasma contact may have deleterious effects on sperm, oocyte, 
uterine environment and in turn, offspring health. In particular, the 
programming of future adiposity and metabolic phenotype in male 
offspring is dependent on this interaction. Using an animal model, 
the group investigated the effect on offspring of excluding the plasma 
fraction of seminal fluid by surgical excision of the seminal vesicle 
gland. Fertilization was reduced, and placental development was 
impaired but most importantly, male offspring were severely affected in 
terms of growth trajectory and metabolic obesity, distorted metabolic 
hormones, reduced glucose tolerance, and hypertension. This carefully 
designed study showed compelling evidence that these effects were due 
to both sperm damage and seminal fluid deficiency on the female tract. 
The absence of seminal plasma was associated with a down‑regulation 
of the embryotrophic factors Lif, Csf2, Il6, and Egf concomitant with 
an up‑regulation of the apoptosis‑inducing factor Trail in the oviduct.95
Given that many of these differences will persist throughout the 
lifetime of these offspring, there is a public health obligation to monitor 
them. Increased public awareness and early screening/prevention or 
lifestyle interventions may safeguard the health of ART‑conceived 
individuals. In addition, the impact of ART procedures such as 
ovarian stimulation, sperm manipulation, and gamete/embryo culture 
conditions, on the epigenetic status of the embryo, with implications 
for the long‑term health of the offspring, require elucidation.
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